Research

Peer-Reviewed Publications, Seminars and Presentations

Dr. Pallavi Upadhyay • Jan. 30, 2023

Explore our latest peer-reviewed publications, seminars, and presentations conducted by Dr. Pallavi Upadhyay, Director of Scientific and Clinical Affairs, Dr. Vijay Singh, Vice President of Research & Development and Jay Reddy, PhD, Senior Vice President of Laboratory & Clinical Strategy.

Explore our latest peer-reviewed publications, seminars, and presentations conducted by Dr. Pallavi Upadhyay, Director of Scientific and Clinical Affairs, Dr. Vijay Singh, Vice President of Research & Development and Jay Reddy, PhD, Senior Vice President of Laboratory & Clinical Strategy.

  1. Alexander BD, Irish WD, Rosato AE, Eisenstein BI, Fragala MS, Goldberg SE, Nash DB (2025). Is Pathogen Molecular Testing Reshaping Outpatient Antibiotic Prescribing? Am J Med Qual. 2025.
    https://pmc.ncbi.nlm.nih.gov/articles/PMC11761054/
  2. Evans A, Singh V, Upadhyay P, Fragala MS, French AJ, Goldberg SE, Reddy J (2025). Molecular Testing for Respiratory Tract Infections May Have Favorable Impact on Real-world Healthcare Costs. American Journal of Infect Dis. 2025
    https://thescipub.com/abstract/ajidsp.2024.46.49
  3. French AJ, Fragala MS, Evans AS, Upadhyay P, Goldberg SE, Reddy J (2025). Real World Evaluation of Next-Day Molecular Respiratory Infectious Disease Testing on Healthcare Resource Utilization and Costs. Clinicoecon Outcomes Res. 2025
    https://pubmed.ncbi.nlm.nih.gov/39958679/
  4. Evans A, Doshi R, Yeaw J, Coyle K, Goldberg S, Wang E, Fragala MS, Reddy J (2024). Healthcare utilization and costs following molecular diagnostic testing among patients with vaginitis. J Comp Eff Res. 2024
    https://pubmed.ncbi.nlm.nih.gov/39611300/
  5. Evans A, Fragala MS, Upadhyay P, French A, Goldberg SE, Reddy J (2024). Utilization of Syndromic Vaginitis Diagnostic Testing Reduces 6-Month Follow-Up Outpatient Service Healthcare Costs-A Real-World Data Analysis. Healthcare (Basel). 2024 Nov 5;12(22):2204.
    https://pubmed.ncbi.nlm.nih.gov/39595403/
  6. Upadhyay P, Surur F, Singh V (2024). Performance Assessment of a Multiplex Real-Time PCR Assay for Detection of Viruses Causing Respiratory Tract Infections. Diagnostics. 2024; 14(21):2350.
    https://doi.org/10.3390/diagnostics14212350
  7. Evans A, Singh V, Fragala MS, Upadhyay P, French A, Goldberg SE, Reddy J (2024). Molecular Testing for Women’s Gynecologic Health: Real-World Impact on Health Care Costs. Population Health Management. 2024 Sep 25.
    https://www.liebertpub.com/doi/abs/10.1089/pop.2024.0133?journalCode=pop
  8. Upadhyay P and Singh V (2024). Mycoplasma pneumoniae outbreak in 2023: Post pandemic resurgence of an atypical bacterial pathogen. Cureus.
    https://pubmed.ncbi.nlm.nih.gov/38779270/
  9. Minhaj FS, Singh V, Cohen SE, Townsend M, Scott H, Szumowski J, Hare B, Upadhyay P, Reddy J, Alexander B, Baird N, Navarra T, Priyamvada L, Wynn N, Carson WC, Odafe S, Guagliardo SAJ, Sims E, Rao AK, Satheshkumar PS, Weidle PJ, Hutson CL (2023). Prevalence of undiagnosed monkeypox virus infections during global mpox outbreak, United States, June–September 2022. Emerg Infect Dis.
    https://doi.org/10.3201/eid2911.230940
  10. Upadhyay P, Reddy J, Proctor T, Sorel O, Veereshlingam H, Gandhi M, Wang X, Singh V* (2023). Expanded PCR Panel Testing for Identification of Respiratory Pathogens and Coinfections in Influenza-like Illness. Diagnostics (Basel). 13(12):2014. (*corresponding author)
    https://pubmed.ncbi.nlm.nih.gov/37370910/
  11. Upadhyay P and Singh V (2022). Rhinovirus and SARS-CoV-2 co-circulation: A unique insight on the pandemic. American Journal of Infectious Diseases. 18 (35-27).
    https://thescipub.com/abstract/ajidsp.2022.35.37
  12. Upadhyay P and Granger J (2021). Importance of Nor-naloxone Detection in Compliance Drug Monitoring of Suboxone Medication Assisted Treatment for Opioid Use Disorder. Journal of Pain & Relief. 10 (393), 2
    https://www.omicsonline.org/open-access/importance-of-nornaloxone-detection-in-compliance-drug-monitoring-of-suboxone-medication-assisted-treatment-for-opioid-use-disorde-116951.html
  13. Singh V, Upadhyay P, Reddy J and Granger J (2021). SARS-CoV-2 Respiratory Co-Infections: Incidence of Viral and Bacterial Co-Pathogens. International Journal of Infectious Diseases. 105, 617-620
    https://pubmed.ncbi.nlm.nih.gov/33640570/
  14. De Silva I, Nayek S, Singh V, Reddy J, Granger J and Verbeck G (2020). Paper Spray Mass spectrometry utilizing Teslin substrate for rapid detection of lipid metabolite changes during COVID-19 infection. Analyst (Royal Society of Chemistry). 145 (17), 5725-5732
    https://pubmed.ncbi.nlm.nih.gov/35244659/
  15. Singh V, Wilks C, Reddy J and Granger J (2020). Outpatient Urinary-Tract-Infection-Like Symptoms: Causative Microbial Survey Utilizing Multiplex Quantitative Polymerase Chain Reaction Methodology. Advances in Infectious Diseases. 10 (01), 26
    https://www.scirp.org/journal/paperinformation.aspx?paperid=98864
  16. Singh V, Reddy J and Granger J (2019). A Survey of Viral-bacterial Co-infection in Respiratory Samples Using Multiplex Real Time-PCR. Journal of Infectious Disease and Therapy. 7 (400), 2332-0877
    https://www.healthtrackrx.com/wp-content/uploads/2021/07/A-Survey-of-Viral-bacterial-Co-infection-in-Respiratory-Samples-Using-Multiplex-Real-Time-PCR-.pdf
  1. Upadhyay P. Are We in a ‘Quademic’? COVID-19, Flu, RSV, and Norovirus Infections Surge. Today’s Clinical Lab.
    https://www.clinicallab.com/are-we-in-a-quademic-covid-19-flu-rsv-and-norovirus-infections-surge-28177
  2. Upadhyay P. What Is hMPV, and Could It Be the Next Pandemic? Infection Control Today.
    https://www.infectioncontroltoday.com/view/what-is-hmpv-could-it-be-next-pandemic-
  3. Upadhyay P. Latest Update on Antimicrobial Resistant Gonorrhea: Challenges and Control Measures. Infection Control Today.
    https://www.infectioncontroltoday.com/view/latest-update-antimicrobial-resistant-gonorrhea-challenges-control-measures
  4. Upadhyay P. Everything You Need to Know About RSV. Feb 27, 2023. Today’s Clinical Lab.
    https://www.clinicallab.com/everything-you-need-to-know-about-rsv-27097
  5. Upadhyay P. Testing for Monkeypox Virus Infections. Nov 01, 2022. Today’s Clinical Lab.
    https://www.clinicallab.com/trends/monkeypox-in-the-clinical-lab/testing-for-monkeypox-virus-coinfections-26839
  6. Upadhyay P. Four Decades of HIV Testing: Where Do We Stand? Sep 22, 2022. Today’s Clinical Lab.
    https://www.clinicallab.com/trends/infectious-diseases/four-decades-of-hiv-testing-where-do-we-stand-26736
  7. Upadhyay P. Monkeypox: What Do We Know So Far? July 6, 2022. Today’s Clinical Lab.
    https://www.clinicallab.com/monkeypox-what-do-we-know-so-far-26585
  8. Upadhyay P. Current challenges facing lab developed tests. June 6, 2022. Today’s Clinical Lab.
    https://www.clinicallab.com/trends/clinical-lab-business-management/current-challenges-facing-lab-developed-tests-26502
  9. Upadhyay P. (2022) How SARS-CoV-2 Variants Impact COVID-19 Testing. Feb 2, 2022. Today’s Clinical Lab.
    https://www.clinicallab.com/trends/covid-19-testing/how-sars-cov-2-variants-impact-covid-19-testing-26225
  10. Upadhyay P. The Dangers of COVID-19 Coinfections. Jan 5, 2022. Clinical Lab Manager.
    https://www.clinicallab.com/trends/covid-19-testing/the-danger-of-covid-19-coinfections-26153
  11. Upadhyay P. Novel Psychoactive Substances: Testing Challenges and Strategies. Nov 16, 2021. Clinical Lab Manager.
    https://www.clinicallab.com/trends/drug-testing/novel-psychoactive-substances-testing-challenges-and-strategies-26051
  12. Upadhyay P. Using Advanced Software to Speed Diagnostic Testing. Sep 30, 2021. Clinical Lab Manager.
    https://www.clinicallab.com/using-advanced-software-to-speed-diagnostic-testing-25763
  13. Upadhyay P. Mobile Drug Testing: Driving the Future of Compliance Drug Monitoring. Sep 7, 2021. Clinical Lab Manager.
    https://www.clinicallab.com/trends/drug-testing/mobile-drug-testing-driving-the-future-of-compliance-drug-monitoring-25910
  1. Singh V. Exploring Molecular Diagnostics: Validating a Multiplex STI Panel with Non-Invasive Sample Types. Industry and Science Showcase. AMP 2023, Salt Lake City, UT (Nov 14-18, 2023)
  2. Singh V. Validation of A New STI Multiplex PCR Assay. Webinar for DarkDaily Group. (Sep 27, 2023).
    https://info.darkdaily.com/webinar-multiplex-pcr-four-common-sti-tests
  3. Singh V. Repurposing the COVID-19 Workflow in a Post-COVID Infectious Disease Lab. Seminar for: Executive War College 2023. (Apr 25, 2023), New Orleans LA.
  4. Upadhyay P. Studying Coinfections: How Syndromic Multiplex PCR Testing Can Help. Webinar for: Today’s Clinical Lab (May 9, 2022).
    https://www.clinicallab.com/2023-pathology-infectious-disease-digital-forum-27032
  5. Singh V. Molecular Testing for Respiratory Tract Infections: Preparing for an Uncertain Flu Season and the Use of Expanded RTI Panels. Fisher Healthcare Webinar (Aug 19, 2022)
    https://www.fishersci.com/us/en/healthcare-products/webinars/molecular-testing-respiratory-tract-infections-preparing-an-uncertain-flu-season-the-appropriate-use-expanded-rti-panels.html
  6. Upadhyay P. Webinar: Improving Workflow and Turnaround Time in Molecular Diagnostics Labs. Webinar for: Today’s Clinical Lab (Apr 29, 2022).
    https://www.clinicallab.com/improving-workflow-and-turnaround-time-in-molecular-diagnostics-labs-26410
  7. Upadhyay P. Automation in Workflow and Data Analysis: A Molecular Diagnostics Laboratory Perspective. Presented at: LTCON Webinar Series – Indigo Bioautomation (November 18, 2021).
    https://pheedloop.com/LTCON21/site/speakers/
  8. Singh V. Challenges of establishing Laboratory Developed Tests. Labroots Webinar (October 5, 2021).
    https://www.thermofisher.com/us/en/home/global/forms/life-science/molecular-tests-clinical-labs/thank-you.html
  9. Singh V. SARS-CoV-2 and Co-infections: What to expect. National Association of Occupational Health Professionals Webinar (December 15, 2020)
  10. Singh V. SARS-CoV-2 and Co-infections: A detailed survey of viral and bacterial respiratory pathogens. Labroots Webinar (September 30, 2020)
    https://www.youtube.com/watch?v=o1R_jg8AUOk
  11. Singh V. Developing an optimized COVID-19 diagnostic test. Labroots Webinar (July 1, 2020)
  12. Singh V. Navigating the reimbursement landscape: A laboratory perspective, AMP Annual Meeting, Baltimore, MD (November 6, 2019)
  13. Singh V. What you’re missing in your respiratory pathogen detection. Clinical Laboratory Education, Fisher Healthcare Webinar (June 24, 2019)
    https://www.fishersci.com/us/en/healthcare-products/webinars/what-youre-missing-respirator-pathogen-detection.html
  14. Singh V. Micro- and Nanofluidic Real-time PCR Syndromic Solutions for Respiratory Pathogen Detection. Industry and Science Showcase. ASM Microbe, San Francisco, CA (June 20-24, 2019)
  1. Upadhyay P, Surur F, Vallabhaneni A, Adla K, Singh V. Clinical Performance Comparison of Three Multiplex RT-PCR assays for Detection of SARS-CoV-2, Flu A, Flu B and RSV in Symptomatic Respiratory Samples. AMP Annual Conference. Vancouver, BC (Nov 2024)
  2. Upadhyay P, Surur V, Vallabhaneni A, Layton S, Adla K, Singh V. Clinical Performance of a Laboratory Developed Multiplexed PCR Assay for the Detection of Respiratory Viral Pathogens. AMP Annual Conference. Vancouver, BC (Nov 2024)
  3. Upadhyay P, Layton S, Vallabhaneni A, Feenstra J, Najarro EH, Changfu W, Singh V. Real time PCR-based research panel assessment for identification of pathogens and antimicrobial resistance genes in wound infections. AMP Annual Conference. Vancouver, BC (Nov 2024)
  4. Upadhyay, P, Vallabhaneni A, Singh V. Correlation of PCR and Culture Values in Evaluating respiratory tract infections results: A molecular diagnostic lab approach to microbial detection. ADLM (formerly AACC), Chicago, IL (Aug 2024)
  5. Upadhyay P, Singh V. Mycoplasma pneumoniae Outbreak in 2023: Post-Pandemic Resurgence of an Atypical Bacterial Pathogen. ADLM, Chicago, IL (Aug 2024)
  6. Upadhyay P, Sorel O, Surur F, Feenstra J, Singh V. Performance Evaluation Of A Multiplex Rt-pcr Assay For Detection Of Viruses Causing Respiratory Tract Infections. ASM Microbe, Atlanta GA (June 2024)
  7. Upadhyay P, Singh V. Mycoplasma pneumoniae outbreak in 2023: concentration in the pediatric and adolescent population infections. American Association of Nurse Practitioners Annual Conference (AANP), Nashville, TN (July 2024)
  8. Vallabhaneni A, Ager E, Upadhyay P, Rosato A, Alexander B, Singh V. Nanofluidic PCR Assay Versus Urine Culture for Diagnosis of Urinary Tract Infection: A Comparison and Correlation of Cycle Threshold and Colony Forming Units. AMP Annual Conference, Salt Lake City, UT (Nov 14-18, 2023)
  9. Ager E, Vallabhaneni A, Upadhyay P, Singh V. Correlating Culture Colony Forming Units to PCR Cycle Threshold Values in Urinary Tract Infections. AMP Annual Conference, Salt Lake City, UT (Nov 14-18, 2023)
  10. Upadhyay P, Surur F, Singh V. Clinical performance evaluation of a multiplex RT-PCR assay for detection of pathogens associated with sexually transmitted infections. AMP Annual Conference, Salt Lake City, UT (Nov 14-18, 2023)
  11. Upadhyay P and Singh V. Analytical and Clinical Validation of a Multiplex RT-PCR based Mpox Assay. ADLM (formerly AACC), Anaheim, CA (July 23-27, 2023)
  12. Upadhyay P and Singh V. Mpox Outbreak In The United States: A Clinical Diagnostics Laboratory Perspective. ASM Microbe, Houston, TX (June 15-19, 2023)
  13. Upadhyay P, Surur F, Kim G, Singh V, Reddy J, Proctor T, Gandhi M. Expanded PCR panel testing for Identification of Respiratory Pathogens and Coinfections in Influenza-like Illness. AMP Annual conference, Phoenix, AZ (Nov 2-6, 2022)
  14. Upadhyay P, Surur F, Kim G, Reddy J, Shakir S, Hanson K, Alexander B, Singh V. A comparative analysis of the detection of UTI pathogens via culture method and the Open Array-nanofluidic real time PCR method. ID week (IDSA), Washington, DC (Oct 19-23, 2022)
  15. Upadhyay P and Singh V. Changes in Sexually Transmitted Infections in the Covid Landscape. ASM Microbe, Washington, DC (June 9 – 13, 2022)
  16. Upadhyay P and Singh V. COVID-19 and its Impact on other Respiratory Viral Infections. Clinical Virology Symposium, West Palm Beach, FL (May 1-4, 2022)
  17. Singh V, Reddy J and Granger J. Real-Time PCR based detection of viral-bacterial co-infections of the respiratory tract. ASM Microbe, San Francisco, CA (June 20-24, 2019)

Dr. Pallavi Upadhyay

Director of Scientific and Clinical Affairs

Dr. Pallavi Upadhyay

Director of Scientific and Clinical Affairs

Related Articles and White papers

HealthTrackRx • Jul 12, 2021

Meet Vijay Singh, Vice President of Research & Development

→

HealthTrackRx • Jun 13, 2023

Expanded PCR Panel Testing for Identification of Respiratory Pathogens and Coinfections in Influenza-like Illness

→

Dr. Jay Reddy • Feb 20, 2015

Meet Dr. Jay Reddy: Chief Scientific Officer

→

Dr. Pallavi Upadhyay • Jan. 30, 2023

Explore our latest peer-reviewed publications, seminars, and presentations conducted by Dr. Pallavi Upadhyay, Director of Scientific and Clinical Affairs, Dr. Vijay Singh, Vice President of Research & Development and Jay Reddy, PhD, Senior Vice President of Laboratory & Clinical Strategy.

Explore our latest peer-reviewed publications, seminars, and presentations conducted by Dr. Pallavi Upadhyay, Director of Scientific and Clinical Affairs, Dr. Vijay Singh, Vice President of Research & Development and Jay Reddy, PhD, Senior Vice President of Laboratory & Clinical Strategy.

  1. Alexander BD, Irish WD, Rosato AE, Eisenstein BI, Fragala MS, Goldberg SE, Nash DB (2025). Is Pathogen Molecular Testing Reshaping Outpatient Antibiotic Prescribing? Am J Med Qual. 2025.
    https://pmc.ncbi.nlm.nih.gov/articles/PMC11761054/
  2. Evans A, Singh V, Upadhyay P, Fragala MS, French AJ, Goldberg SE, Reddy J (2025). Molecular Testing for Respiratory Tract Infections May Have Favorable Impact on Real-world Healthcare Costs. American Journal of Infect Dis. 2025
    https://thescipub.com/abstract/ajidsp.2024.46.49
  3. French AJ, Fragala MS, Evans AS, Upadhyay P, Goldberg SE, Reddy J (2025). Real World Evaluation of Next-Day Molecular Respiratory Infectious Disease Testing on Healthcare Resource Utilization and Costs. Clinicoecon Outcomes Res. 2025
    https://pubmed.ncbi.nlm.nih.gov/39958679/
  4. Evans A, Doshi R, Yeaw J, Coyle K, Goldberg S, Wang E, Fragala MS, Reddy J (2024). Healthcare utilization and costs following molecular diagnostic testing among patients with vaginitis. J Comp Eff Res. 2024
    https://pubmed.ncbi.nlm.nih.gov/39611300/
  5. Evans A, Fragala MS, Upadhyay P, French A, Goldberg SE, Reddy J (2024). Utilization of Syndromic Vaginitis Diagnostic Testing Reduces 6-Month Follow-Up Outpatient Service Healthcare Costs-A Real-World Data Analysis. Healthcare (Basel). 2024 Nov 5;12(22):2204.
    https://pubmed.ncbi.nlm.nih.gov/39595403/
  6. Upadhyay P, Surur F, Singh V (2024). Performance Assessment of a Multiplex Real-Time PCR Assay for Detection of Viruses Causing Respiratory Tract Infections. Diagnostics. 2024; 14(21):2350.
    https://doi.org/10.3390/diagnostics14212350
  7. Evans A, Singh V, Fragala MS, Upadhyay P, French A, Goldberg SE, Reddy J (2024). Molecular Testing for Women’s Gynecologic Health: Real-World Impact on Health Care Costs. Population Health Management. 2024 Sep 25.
    https://www.liebertpub.com/doi/abs/10.1089/pop.2024.0133?journalCode=pop
  8. Upadhyay P and Singh V (2024). Mycoplasma pneumoniae outbreak in 2023: Post pandemic resurgence of an atypical bacterial pathogen. Cureus.
    https://pubmed.ncbi.nlm.nih.gov/38779270/
  9. Minhaj FS, Singh V, Cohen SE, Townsend M, Scott H, Szumowski J, Hare B, Upadhyay P, Reddy J, Alexander B, Baird N, Navarra T, Priyamvada L, Wynn N, Carson WC, Odafe S, Guagliardo SAJ, Sims E, Rao AK, Satheshkumar PS, Weidle PJ, Hutson CL (2023). Prevalence of undiagnosed monkeypox virus infections during global mpox outbreak, United States, June–September 2022. Emerg Infect Dis.
    https://doi.org/10.3201/eid2911.230940
  10. Upadhyay P, Reddy J, Proctor T, Sorel O, Veereshlingam H, Gandhi M, Wang X, Singh V* (2023). Expanded PCR Panel Testing for Identification of Respiratory Pathogens and Coinfections in Influenza-like Illness. Diagnostics (Basel). 13(12):2014. (*corresponding author)
    https://pubmed.ncbi.nlm.nih.gov/37370910/
  11. Upadhyay P and Singh V (2022). Rhinovirus and SARS-CoV-2 co-circulation: A unique insight on the pandemic. American Journal of Infectious Diseases. 18 (35-27).
    https://thescipub.com/abstract/ajidsp.2022.35.37
  12. Upadhyay P and Granger J (2021). Importance of Nor-naloxone Detection in Compliance Drug Monitoring of Suboxone Medication Assisted Treatment for Opioid Use Disorder. Journal of Pain & Relief. 10 (393), 2
    https://www.omicsonline.org/open-access/importance-of-nornaloxone-detection-in-compliance-drug-monitoring-of-suboxone-medication-assisted-treatment-for-opioid-use-disorde-116951.html
  13. Singh V, Upadhyay P, Reddy J and Granger J (2021). SARS-CoV-2 Respiratory Co-Infections: Incidence of Viral and Bacterial Co-Pathogens. International Journal of Infectious Diseases. 105, 617-620
    https://pubmed.ncbi.nlm.nih.gov/33640570/
  14. De Silva I, Nayek S, Singh V, Reddy J, Granger J and Verbeck G (2020). Paper Spray Mass spectrometry utilizing Teslin substrate for rapid detection of lipid metabolite changes during COVID-19 infection. Analyst (Royal Society of Chemistry). 145 (17), 5725-5732
    https://pubmed.ncbi.nlm.nih.gov/35244659/
  15. Singh V, Wilks C, Reddy J and Granger J (2020). Outpatient Urinary-Tract-Infection-Like Symptoms: Causative Microbial Survey Utilizing Multiplex Quantitative Polymerase Chain Reaction Methodology. Advances in Infectious Diseases. 10 (01), 26
    https://www.scirp.org/journal/paperinformation.aspx?paperid=98864
  16. Singh V, Reddy J and Granger J (2019). A Survey of Viral-bacterial Co-infection in Respiratory Samples Using Multiplex Real Time-PCR. Journal of Infectious Disease and Therapy. 7 (400), 2332-0877
    https://www.healthtrackrx.com/wp-content/uploads/2021/07/A-Survey-of-Viral-bacterial-Co-infection-in-Respiratory-Samples-Using-Multiplex-Real-Time-PCR-.pdf
  1. Upadhyay P. Are We in a ‘Quademic’? COVID-19, Flu, RSV, and Norovirus Infections Surge. Today’s Clinical Lab.
    https://www.clinicallab.com/are-we-in-a-quademic-covid-19-flu-rsv-and-norovirus-infections-surge-28177
  2. Upadhyay P. What Is hMPV, and Could It Be the Next Pandemic? Infection Control Today.
    https://www.infectioncontroltoday.com/view/what-is-hmpv-could-it-be-next-pandemic-
  3. Upadhyay P. Latest Update on Antimicrobial Resistant Gonorrhea: Challenges and Control Measures. Infection Control Today.
    https://www.infectioncontroltoday.com/view/latest-update-antimicrobial-resistant-gonorrhea-challenges-control-measures
  4. Upadhyay P. Everything You Need to Know About RSV. Feb 27, 2023. Today’s Clinical Lab.
    https://www.clinicallab.com/everything-you-need-to-know-about-rsv-27097
  5. Upadhyay P. Testing for Monkeypox Virus Infections. Nov 01, 2022. Today’s Clinical Lab.
    https://www.clinicallab.com/trends/monkeypox-in-the-clinical-lab/testing-for-monkeypox-virus-coinfections-26839
  6. Upadhyay P. Four Decades of HIV Testing: Where Do We Stand? Sep 22, 2022. Today’s Clinical Lab.
    https://www.clinicallab.com/trends/infectious-diseases/four-decades-of-hiv-testing-where-do-we-stand-26736
  7. Upadhyay P. Monkeypox: What Do We Know So Far? July 6, 2022. Today’s Clinical Lab.
    https://www.clinicallab.com/monkeypox-what-do-we-know-so-far-26585
  8. Upadhyay P. Current challenges facing lab developed tests. June 6, 2022. Today’s Clinical Lab.
    https://www.clinicallab.com/trends/clinical-lab-business-management/current-challenges-facing-lab-developed-tests-26502
  9. Upadhyay P. (2022) How SARS-CoV-2 Variants Impact COVID-19 Testing. Feb 2, 2022. Today’s Clinical Lab.
    https://www.clinicallab.com/trends/covid-19-testing/how-sars-cov-2-variants-impact-covid-19-testing-26225
  10. Upadhyay P. The Dangers of COVID-19 Coinfections. Jan 5, 2022. Clinical Lab Manager.
    https://www.clinicallab.com/trends/covid-19-testing/the-danger-of-covid-19-coinfections-26153
  11. Upadhyay P. Novel Psychoactive Substances: Testing Challenges and Strategies. Nov 16, 2021. Clinical Lab Manager.
    https://www.clinicallab.com/trends/drug-testing/novel-psychoactive-substances-testing-challenges-and-strategies-26051
  12. Upadhyay P. Using Advanced Software to Speed Diagnostic Testing. Sep 30, 2021. Clinical Lab Manager.
    https://www.clinicallab.com/using-advanced-software-to-speed-diagnostic-testing-25763
  13. Upadhyay P. Mobile Drug Testing: Driving the Future of Compliance Drug Monitoring. Sep 7, 2021. Clinical Lab Manager.
    https://www.clinicallab.com/trends/drug-testing/mobile-drug-testing-driving-the-future-of-compliance-drug-monitoring-25910
  1. Singh V. Exploring Molecular Diagnostics: Validating a Multiplex STI Panel with Non-Invasive Sample Types. Industry and Science Showcase. AMP 2023, Salt Lake City, UT (Nov 14-18, 2023)
  2. Singh V. Validation of A New STI Multiplex PCR Assay. Webinar for DarkDaily Group. (Sep 27, 2023).
    https://info.darkdaily.com/webinar-multiplex-pcr-four-common-sti-tests
  3. Singh V. Repurposing the COVID-19 Workflow in a Post-COVID Infectious Disease Lab. Seminar for: Executive War College 2023. (Apr 25, 2023), New Orleans LA.
  4. Upadhyay P. Studying Coinfections: How Syndromic Multiplex PCR Testing Can Help. Webinar for: Today’s Clinical Lab (May 9, 2022).
    https://www.clinicallab.com/2023-pathology-infectious-disease-digital-forum-27032
  5. Singh V. Molecular Testing for Respiratory Tract Infections: Preparing for an Uncertain Flu Season and the Use of Expanded RTI Panels. Fisher Healthcare Webinar (Aug 19, 2022)
    https://www.fishersci.com/us/en/healthcare-products/webinars/molecular-testing-respiratory-tract-infections-preparing-an-uncertain-flu-season-the-appropriate-use-expanded-rti-panels.html
  6. Upadhyay P. Webinar: Improving Workflow and Turnaround Time in Molecular Diagnostics Labs. Webinar for: Today’s Clinical Lab (Apr 29, 2022).
    https://www.clinicallab.com/improving-workflow-and-turnaround-time-in-molecular-diagnostics-labs-26410
  7. Upadhyay P. Automation in Workflow and Data Analysis: A Molecular Diagnostics Laboratory Perspective. Presented at: LTCON Webinar Series – Indigo Bioautomation (November 18, 2021).
    https://pheedloop.com/LTCON21/site/speakers/
  8. Singh V. Challenges of establishing Laboratory Developed Tests. Labroots Webinar (October 5, 2021).
    https://www.thermofisher.com/us/en/home/global/forms/life-science/molecular-tests-clinical-labs/thank-you.html
  9. Singh V. SARS-CoV-2 and Co-infections: What to expect. National Association of Occupational Health Professionals Webinar (December 15, 2020)
  10. Singh V. SARS-CoV-2 and Co-infections: A detailed survey of viral and bacterial respiratory pathogens. Labroots Webinar (September 30, 2020)
    https://www.youtube.com/watch?v=o1R_jg8AUOk
  11. Singh V. Developing an optimized COVID-19 diagnostic test. Labroots Webinar (July 1, 2020)
  12. Singh V. Navigating the reimbursement landscape: A laboratory perspective, AMP Annual Meeting, Baltimore, MD (November 6, 2019)
  13. Singh V. What you’re missing in your respiratory pathogen detection. Clinical Laboratory Education, Fisher Healthcare Webinar (June 24, 2019)
    https://www.fishersci.com/us/en/healthcare-products/webinars/what-youre-missing-respirator-pathogen-detection.html
  14. Singh V. Micro- and Nanofluidic Real-time PCR Syndromic Solutions for Respiratory Pathogen Detection. Industry and Science Showcase. ASM Microbe, San Francisco, CA (June 20-24, 2019)
  1. Upadhyay P, Surur F, Vallabhaneni A, Adla K, Singh V. Clinical Performance Comparison of Three Multiplex RT-PCR assays for Detection of SARS-CoV-2, Flu A, Flu B and RSV in Symptomatic Respiratory Samples. AMP Annual Conference. Vancouver, BC (Nov 2024)
  2. Upadhyay P, Surur V, Vallabhaneni A, Layton S, Adla K, Singh V. Clinical Performance of a Laboratory Developed Multiplexed PCR Assay for the Detection of Respiratory Viral Pathogens. AMP Annual Conference. Vancouver, BC (Nov 2024)
  3. Upadhyay P, Layton S, Vallabhaneni A, Feenstra J, Najarro EH, Changfu W, Singh V. Real time PCR-based research panel assessment for identification of pathogens and antimicrobial resistance genes in wound infections. AMP Annual Conference. Vancouver, BC (Nov 2024)
  4. Upadhyay, P, Vallabhaneni A, Singh V. Correlation of PCR and Culture Values in Evaluating respiratory tract infections results: A molecular diagnostic lab approach to microbial detection. ADLM (formerly AACC), Chicago, IL (Aug 2024)
  5. Upadhyay P, Singh V. Mycoplasma pneumoniae Outbreak in 2023: Post-Pandemic Resurgence of an Atypical Bacterial Pathogen. ADLM, Chicago, IL (Aug 2024)
  6. Upadhyay P, Sorel O, Surur F, Feenstra J, Singh V. Performance Evaluation Of A Multiplex Rt-pcr Assay For Detection Of Viruses Causing Respiratory Tract Infections. ASM Microbe, Atlanta GA (June 2024)
  7. Upadhyay P, Singh V. Mycoplasma pneumoniae outbreak in 2023: concentration in the pediatric and adolescent population infections. American Association of Nurse Practitioners Annual Conference (AANP), Nashville, TN (July 2024)
  8. Vallabhaneni A, Ager E, Upadhyay P, Rosato A, Alexander B, Singh V. Nanofluidic PCR Assay Versus Urine Culture for Diagnosis of Urinary Tract Infection: A Comparison and Correlation of Cycle Threshold and Colony Forming Units. AMP Annual Conference, Salt Lake City, UT (Nov 14-18, 2023)
  9. Ager E, Vallabhaneni A, Upadhyay P, Singh V. Correlating Culture Colony Forming Units to PCR Cycle Threshold Values in Urinary Tract Infections. AMP Annual Conference, Salt Lake City, UT (Nov 14-18, 2023)
  10. Upadhyay P, Surur F, Singh V. Clinical performance evaluation of a multiplex RT-PCR assay for detection of pathogens associated with sexually transmitted infections. AMP Annual Conference, Salt Lake City, UT (Nov 14-18, 2023)
  11. Upadhyay P and Singh V. Analytical and Clinical Validation of a Multiplex RT-PCR based Mpox Assay. ADLM (formerly AACC), Anaheim, CA (July 23-27, 2023)
  12. Upadhyay P and Singh V. Mpox Outbreak In The United States: A Clinical Diagnostics Laboratory Perspective. ASM Microbe, Houston, TX (June 15-19, 2023)
  13. Upadhyay P, Surur F, Kim G, Singh V, Reddy J, Proctor T, Gandhi M. Expanded PCR panel testing for Identification of Respiratory Pathogens and Coinfections in Influenza-like Illness. AMP Annual conference, Phoenix, AZ (Nov 2-6, 2022)
  14. Upadhyay P, Surur F, Kim G, Reddy J, Shakir S, Hanson K, Alexander B, Singh V. A comparative analysis of the detection of UTI pathogens via culture method and the Open Array-nanofluidic real time PCR method. ID week (IDSA), Washington, DC (Oct 19-23, 2022)
  15. Upadhyay P and Singh V. Changes in Sexually Transmitted Infections in the Covid Landscape. ASM Microbe, Washington, DC (June 9 – 13, 2022)
  16. Upadhyay P and Singh V. COVID-19 and its Impact on other Respiratory Viral Infections. Clinical Virology Symposium, West Palm Beach, FL (May 1-4, 2022)
  17. Singh V, Reddy J and Granger J. Real-Time PCR based detection of viral-bacterial co-infections of the respiratory tract. ASM Microbe, San Francisco, CA (June 20-24, 2019)

Dr. Pallavi Upadhyay

Director of Scientific and Clinical Affairs

Dr. Pallavi Upadhyay

Director of Scientific and Clinical Affairs

Related Articles and White papers

HealthTrackRx • Mar 13, 2025

Advancing Patient Care with HealthTrackRx: A Conversation with Dr. Nathan Newman

→

Dr. Pallavi Upadhyay • Feb 3, 2025

What Is hMPV, and Could It Be the Next Pandemic?

→

Dr. Pallavi Upadhyay • Jul 10, 2021

Meet Dr. Pallavi Upadhyay: Director of Scientific and Clinical Affairs at HealthTrackRx

→